Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: A meta-analysis

Chest

Volumn 129, Issue 3, 2006, Pages 783-790

  Tokuda, Yasuharu ^a,e   Matsushima, Dai ^b   Stein, Gerald H ^c   Miyagi, Seishirou ^d  

^a Okinawa Prefectural Chubu Hospital   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d Muribushi Project of Residency Program   (Japan)

^e NONE   (United States)

Author keywords

Empyema; Fibrinolysis; Pleural effusion

Indexed keywords

FIBRINOLYTIC AGENT; PLACEBO; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EMBASE; FIBRINOLYTIC THERAPY; GRAM STAINING; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; PLEURA EFFUSION; PLEURA EMPYEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SEPSIS; STATISTICAL ANALYSIS; SURVIVAL TIME; SYSTEMATIC REVIEW; THORAX DRAINAGE; TREATMENT DURATION; TREATMENT OUTCOME; TUBE;

EID: 33645116954     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.3.783     Document Type: Article

References (23)

1. Davies CW, Kearney SE, Gleeson FV, et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160:1682-1687
2. Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. Q J Med 1996; 89:285-289
3. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax 2003; 58(suppl 2):ii18-ii28
4. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004:CD002312
5. Diacon AH, Theron J, Schuurmans MM, et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004; 170:49-53
6. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52:416-421
7. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med 1999; 159:37-42
8. Maskell NA, Davies CW, Nunn AJ, et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352:865-874
9. Heffner JE. Multicenter trials of treatment for empyema: after all these years. N Engl J Med 2005; 352:926-928
10. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273:408-412
11. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358:9-15
12. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement.-Quality of Reporting of Meta-analyses. Lancet 1999; 354:1896-1900
13. Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd ed. London, UK: BMJ, 2001
14. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997; 111:275-279
15. Lim TK, Chin NK, Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur Respir J 1999; 13:514-518
16. Talib SH, Verma GR, Arshad M, et al. Utility of intrapleural streptokinase in management of chronic empyemas. J Assoc Phys India 2003; 51:464-468
17. Kwak SM, Park CS, Cho JH, et al. The effects of urotonase instillation therapy via percutaneous transthoracic catheter in loculated tuberculous pleural effusion: a randomized prospective study. Yonsei Med J 2004; 45:822-828
18. Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995; 108:299-301
19. Tuncozgur B, Ustunsoy H, Sivrikoz MC, et al. Intrapleural urokinase in the management of parapneumonic empyema; a randomised controlled trial. Int J Clin Pract 2001; 55:658-660
20. Temes RT, Follis F, Kessler RM, et al. Intrapleural fibrinolytics in management of empyema thoracis. Chest 1996; 110:102-106
21. Maskell NA, Gleeson FV. Images in clinical medicine: effect of intrapleural streptokinase on a loculated malignant pleural effusion. N Engl J Med 2003; 348:e4
22. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000; 117:1728-1733
23. Bouros D, Antoniou KM, Chalkiadakis G, et al. The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics. Surg Endosc 2002; 16:151-154